This inventor holds 5 USPTO granted patents. Top assignee: Cedars-Sinai Medical Center. Active years: 2002-2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Burlingame, CA (US) (2002)
- Los Angeles, CA (US) (2004 - 2005)
Company Filing History:
Years Active: 2002-2005
Title: Lin Pei: Innovator in Polypeptide Research
Introduction
Lin Pei is a distinguished inventor based in Los Angeles, California. He has made significant contributions to the field of biotechnology, particularly in the area of polypeptide research. With a total of five patents to his name, Lin Pei is recognized for his innovative approaches to understanding and utilizing the pituitary-tumor-transforming-gene (PTTG).
Latest Patents
Among his latest patents are two notable inventions related to the PTTG polypeptide. The first patent focuses on the rat PTTG polypeptide and the method for producing it. This invention details how polypeptides are expressed by the PTTG gene, which is crucial for the production of recombinant proteins. The nucleic acids involved can be linked to vectors and delivered to mammals to address deficiencies in endogenous protein expression. This technology has applications in diagnostic assays and the production of therapeutic compositions. The second patent pertains to the human PTTG polypeptide, which shares similar methodologies and applications as the rat version. Both patents highlight the potential for developing anti-PTTG antibodies and various kits that utilize these nucleic acids and proteins.
Career Highlights
Lin Pei is currently affiliated with Cedars-Sinai Medical Center, where he continues to advance his research in biotechnology. His work has garnered attention for its potential impact on medical diagnostics and therapeutic solutions. His innovative spirit and dedication to research have positioned him as a key figure in his field.
Collaborations
Lin Pei collaborates with esteemed colleagues, including Shlomo Melmed, to further enhance the scope and impact of his research. Their combined expertise contributes to the advancement of knowledge in the field of polypeptide research.
Conclusion
Lin Pei's contributions to biotechnology, particularly through his patents on PTTG polypeptides, demonstrate his commitment to innovation and research. His work at Cedars-Sinai Medical Center continues to pave the way for advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile